April 10, 2014. Source: GeneWatch UK
Environmental and civil society groups today warned the Brazilian regulator of genetically modified organisms (GMOs), CTNBio, not to approve commercial releases of GM mosquitoes in Brazil without full public consultation, access to conclusive field trials data and a post release monitoring plan. The groups cautioned that the consequences for human health and the environment are poorly understood and need to be further studied.
The GM Aedes aegypti mosquitoes are produced by UK company Oxitec and the decision follows extensive lobbying by the UK Government to try to create an export market for its products (1). The company, which has close links to the multinational agribusiness Syngenta, also has GM agricultural pests, such as GM fruit flies, at an experimental stage and approval for field trials are pending in Brazil.
“There are no data showing that this GM mosquito actually reduces dengue incidence. In the case it is approved for commercial use, the decision will have been based much more on propaganda than on concrete data from field studies”, said Gabriel Fernandes, advisor with the Brazilian organization AS-PTA.
“Oxitec’s ineffective and risky GM insects are a poor showcase for British exports to Brazil. A desperate desire to prop up British biotech and reward venture capital investors should not blind the UK and Brazilian governments to the risks of this technology”, said Dr Helen Wallace, Director of GeneWatch UK.